Kara Hommerding, PA
Physician Assistant · Colorado Springs, CONPI 1760600159
Payments from drug & device makers
Across 149 payments — averaging $24.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$676
- Johnson & Johnson$627
- Sanofi$550
- Novartis$442
- Sun Pharmaceutical Industries Inc.$247
- UCB, Inc.$165
- plus $981 from 16 others
What the payments were for
- Food & beverage$3,30690%
- Education$38210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 32 | $676 |
| Johnson & Johnson | 17 | $627 |
| Sanofi | 19 | $550 |
| Novartis | 18 | $442 |
| Sun Pharmaceutical Industries Inc. | 9 | $247 |
| UCB, Inc. | 7 | $165 |
| Regeneron Healthcare Solutions, Inc. | 5 | $151 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 7 | $141 |
| Incyte Corporation | 6 | $107 |
| Organon | 7 | $100 |
| Arcutis Biotherapeutics, Inc. | 5 | $98 |
| Lilly USA, LLC | 4 | $84 |
| Amgen | 2 | $64 |
| LEO Pharma Inc. | 2 | $36 |
| Pfizer | 2 | $29 |
| Galderma Laboratories, L.p. | 1 | $28 |
| E.r. Squibb & Sons, L.L.C. | 1 | $27 |
| Krystal Biotech Inc | 1 | $25 |
| Organogenesis Inc. | 1 | $23 |
| Kerecis Limited | 1 | $23 |
| Dermavant Sciences, Inc. | 1 | $23 |
| Almirall LLC | 1 | $21 |
How this compares
$3,688 in reported general payments places this provider in the 90th percentile of 2,849 physician assistant providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 13 | $86,056 |
| Tacrolimus | 19 | $3,974 |
| Ketoconazole | 106 | $2,286 |
| Clobetasol Propionate | 67 | $2,165 |
| Fluorouracil | 19 | $1,512 |
| Metronidazole | 19 | $996 |
| Triamcinolone Acetonide | 60 | $491 |
| Clindamycin Phosphate | 12 | $449 |
| Doxycycline Hyclate | 15 | $257 |
| Nystatin | 17 | $243 |
| Mupirocin | 17 | $147 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Colorado Springs
- Miyoko GreenColorado Springs$16K
- Toni BoykoColorado Springs$12K
- Dominique SwainColorado Springs$10K
- Donald MooreEnglewood$246K
- Neekan AeiniGreenwood Village$234K
- Korby HowellCortez$182K
- Heather FinlaysonLittleton$180K
- Kristen LervikDenver$131K
- Marissa Moritz-GuzikLouisville$94K
- Clayton LabaumeDurango$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.